Alberta Investment Management Corp Eli Lilly & CO Transaction History

Alberta Investment Management Corp

$10.2 Billion
Q3 2024

A detailed history of Alberta Investment Management Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Alberta Investment Management Corp holds 16,400 shares of LLY stock, worth $13 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

16,400

Previous 4,300 281.4%

Holding current value

$13 Million

Previous $3.89 Million 273.21%

% of portfolio

0.14%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$772.14 - $960.02 $9.34 Million - $11.6 Million	12,100 Added 281.4%	16,400 $14.5 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $11.3 Million - $14.2 Million	-15,600 Reduced 78.39%	4,300 $3.89 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $118,440 - $158,456	200 Added 1.02%	19,900 $15.5 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $18.4 Million - $21.7 Million	-35,087 Reduced 64.04%	19,700 $11.5 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $539,028 - $743,132	-1,240 Reduced 2.21%	54,787 $29.4 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $4.71 Million - $6.29 Million	-13,415 Reduced 19.32%	56,027 $26.3 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $3.02 Million - $3.54 Million	9,714 Added 16.26%	69,442 $23.8 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $2.36 Million - $2.76 Million	-7,354 Reduced 10.96%	59,728 $21.9 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $17.1 Million - $19.5 Million	-57,688 Reduced 46.24%	67,082 $21.7 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $10.9 Million - $12.8 Million	39,263 Added 45.92%	124,770 $40.5 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $709,233 - $881,396	-3,022 Reduced 3.41%	85,507 $24.5 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $3.99 Million - $4.95 Million	17,729 Added 25.04%	88,529 $24.5 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $110,800 - $136,355	500 Added 0.71%	70,800 $16.4 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $2.08 Million - $2.69 Million	-11,500 Reduced 14.06%	70,300 $16.1 Million
Q1 2021 May 07, 2021	BUY	$164.32 - $212.72 $1.53 Million - $1.98 Million	9,300 Added 12.83%	81,800 $15.3 Million
Q3 2020 Oct 26, 2020	SELL	$146.22 - $169.13 $1.42 Million - $1.64 Million	-9,700 Reduced 11.8%	72,500 $10.7 Million
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $2.73 Million - $3.28 Million	20,000 Added 32.15%	82,200 $13.5 Million
Q1 2020 May 08, 2020	BUY	$119.05 - $147.35 $4.29 Million - $5.3 Million	36,000 Added 137.4%	62,200 $8.63 Million
Q3 2019 Oct 23, 2019	BUY	$106.79 - $116.16 $2.8 Million - $3.04 Million	26,200 New	26,200 $2.93 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $1.01 Million - $1.18 Million	-9,100 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $1.01 Million - $1.19 Million	9,100 New	9,100 $1.18 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $25 Million - $28 Million	-236,100 Closed	0 $0
Q3 2018 Nov 16, 2018	SELL	$85.86 - $107.31 $8.72 Million - $10.9 Million	-101,600 Reduced 30.09%	236,100 $25.3 Million
Q2 2018 Aug 15, 2018	BUY	$75.7 - $86.88 $20 Million - $22.9 Million	263,900 Added 357.59%	337,700 $28.8 Million
Q1 2018 May 16, 2018	BUY	$74.21 - $87.6 $4.3 Million - $5.08 Million	58,000 Added 367.09%	73,800 $5.71 Million
Q4 2017 Feb 15, 2018	SELL	$81.94 - $87.89 $1.27 Million - $1.36 Million	-15,500 Reduced 49.52%	15,800 $1.33 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $2.41 Million - $2.68 Million	31,300	31,300 $2.68 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.

Account

Alberta Investment Management Corp Eli Lilly & CO Transaction History